Suppr超能文献

急性肾损伤的腹膜透析:技术与剂量

Peritoneal dialysis for acute kidney injury: techniques and dose.

作者信息

Chionh Chang Yin, Soni Sachin, Cruz Dinna N, Ronco Claudio

出版信息

Contrib Nephrol. 2009;163:278-284. doi: 10.1159/000223811. Epub 2009 Jun 3.

Abstract

It has not been clearly shown which modality of dialysis is superior in the management of acute kidney injury (AKI). Most centers in developed countries have adopted extracorporeal blood purification (EBP) strategies, such as continuous or intermittent forms of hemodialysis or hemofiltration, for the supportive management of AKI. On the other hand, the use of peritoneal dialysis (PD) is widespread in developing countries in view of its ease of use, low cost and minimal requirements on infrastructure. The dose of dialysis required for AKI remains controversial, although an augmented dose with a high small solute clearance is advocated until further definitive evidence becomes available. No studies have directly examined the effects of the dose of PD on outcomes in AKI. The targets of dose for PD are inferred from studies conducted with EBP. There are concerns that PD is unable to achieve high clearances required to support a patient with renal failure. However, various techniques have been described which are able to achieve the targets of small solute clearance. These include high volume PD and continuous flow PD. The selection of flexible peritoneal catheters with better catheter function and dialysate flow rates can improve the efficiency of PD. Other aspects of dose should also be examined, including clearance of middle molecular weight toxins as well as adequate fluid removal. With careful selection of techniques to meet the individual demands of the patient, PD is an appropriate modality of dialysis for patients with AKI.

摘要

目前尚未明确哪种透析方式在急性肾损伤(AKI)的管理中更具优势。发达国家的大多数中心已采用体外血液净化(EBP)策略,如连续性或间歇性血液透析或血液滤过,用于AKI的支持性管理。另一方面,鉴于腹膜透析(PD)使用方便、成本低且对基础设施要求 minimal,其在发展中国家广泛应用。AKI所需的透析剂量仍存在争议,尽管在获得进一步的确切证据之前,主张采用高小分子溶质清除率的强化剂量。尚无研究直接考察PD剂量对AKI结局的影响。PD的剂量目标是从EBP相关研究中推断出来的。有人担心PD无法达到支持肾衰竭患者所需的高清除率。然而,已有多种技术被描述能够实现小分子溶质清除目标。这些技术包括大容量PD和持续流动PD。选择具有更好导管功能和透析液流速的柔性腹膜导管可提高PD效率。还应考察剂量的其他方面,包括中分子量毒素的清除以及足够的液体清除。通过仔细选择技术以满足患者的个体需求,PD是AKI患者合适的透析方式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验